XNYS · Healthcare · Medical Devices
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | Q1 2026 | 0.81 | 0.89 | +9.88% | $589.2M | ✅ Beat | +3.22% | -4.15% | — |
| 2026-02-26 | Q4 2025 | 0.83 | 0.95 | +14.46% | $575.8M | ✅ Beat | +3.63% | -4.33% | -14.16% |
| 2025-11-06 |
| Q3 2025 |
| 0.66 |
| 0.75 |
| +13.64% |
| $548.9M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-02-26 | Q4 2024 | 0.92 | 0.98 | +6.52% | $561.0M | ✅ Beat | -4.70% | -5.97% | -5.60% |
| 2024-11-06 | Q3 2024 | 0.62 | 0.73 | +17.74% | $505.2M | ✅ Beat | +2.05% | -0.96% | +1.56% |
| 2024-08-07 | Q2 2024 | 0.60 | 0.62 | +3.33% | $525.2M | ✅ Beat | +7.37% | +6.04% | +7.07% |
| 2024-05-02 | Q1 2024 | 0.48 | 0.50 | +4.17% | $516.3M | ✅ Beat | -1.65% | -2.07% | -5.70% |
| 2024-02-22 | Q4 2023 | 0.74 | 0.79 | +6.76% | $455.0M | ✅ Beat | — | — | — |
Showing last 8 quarters.